Compass Therapeutics Inc.

📍 Boston, United States🗓 Founded 2014👥 43 employees💰 Last funded Oct 2018
Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’ scientific focus is on the relationship between angiogenesis, the immune system and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts. To learn more, visit www.compasstherapeutics.com
4
Total investors
2
Early stage
2
Mid stage
0
Late stage
2014
Founded
Investor geography2 countries
United States
2
China
1
Investor activity2015–2018 · investors recorded per year
2015220182
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Compass Therapeutics Inc.?
Compass Therapeutics Inc. has 4 investors on record on gritt.io, including 2 early-stage backers, 2 mid-stage.
When did Compass Therapeutics Inc. last raise funding?
The most recent investment in Compass Therapeutics Inc. recorded on gritt.io was in October 2018.
When was Compass Therapeutics Inc. founded?
Compass Therapeutics Inc. was founded in 2014.
What industry is Compass Therapeutics Inc. in?
Compass Therapeutics Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Compass Therapeutics Inc. based?
Compass Therapeutics Inc. is headquartered in Boston, United States.